“SC”的搜索结果，显示 31-40 项，共有 2994 项

1. 肾病和高血压- 临床试验- 妙佑医疗国际

   The purpose of this study is to assess the effectiveness of daratumumab SC in treating patients with monoclonal immunoglobulin deposits (PGNMID) by assessing ...

2. 如何充分利用妙佑医疗国际的就诊时间

   SC: Mayo Clinic Breadcrumb. 患者与访客指南 · 为就诊做准备. Sections 为就诊做准备. 您的打包清单 · 如何充分利用妙佑医疗国际的就诊时间 · 让您的就医之旅少一点压力

3. 耳鼻喉科(ENT) /头颈外科- 临床试验- 妙佑医疗国际

   SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...

4. 耳鼻喉科(ENT) /头颈外科- 临床试验- 妙佑医疗国际

   SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...

5. 医疗记录和影像申请- 妙佑医疗国际

   SC: Mayo Clinic Breadcrumb. 患者与访客指南. Sections 患者与访客指南. ‏妙佑医疗国际亚利桑那州院区. Collapse ‏妙佑医疗国际亚利桑那州院区. 来到这里 · 逛院区 · 院区 ...

6. 耳鼻喉科(ENT) /头颈外科- 临床试验- 妙佑医疗国际

   SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...